Bioharvest Sciences IncNASDAQ:BHSTView on Canadian Exchange
- LAST PRICE6.1800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.4800/ 2
- Ask / Lots9.8800/ 2
- Open / Previous Close--- / 6.1800
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BHST |
|---|---|---|
| 09:32 ET | 1206 | 6 |
| 10:15 ET | 100 | 6.2478 |
| 10:26 ET | 400 | 6.18 |
| 11:41 ET | 2100 | 6.06 |
| 11:43 ET | 191 | 6.255 |
| 12:30 ET | 200 | 6.15 |
| 12:51 ET | 400 | 6.15 |
| 01:38 ET | 483 | 6.225 |
| 01:56 ET | 1072 | 6.21 |
| 02:12 ET | 500 | 6.18 |
| 03:53 ET | 1274 | 6.18 |
Yesterday
Nov 18, 2024
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time, from 8:31AM ET on Monday Nov 18, 2024 by Dow Jones
8:31AM ET on Monday Nov 18, 2024 by Dow Jones
Nov 12, 2024
BioHarvest Sciences Begins Trading on the Nasdaq Global Market, from 8:33AM ET on Tuesday Nov 12, 2024 by Dow Jones
8:33AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 7, 2024
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market, from 8:32AM ET on Thursday Nov 07, 2024 by Dow Jones
8:32AM ET on Thursday Nov 07, 2024 by Dow Jones
Oct 23, 2024
BioHarvest Sciences Announces Record Preliminary Third Quarter 2024 Financial Results, from 8:32AM ET on Wednesday Oct 23, 2024 by Dow Jones
8:32AM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Bioharvest Sciences Inc | 149.0M | 0.0x | --- |
Company Information
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals: as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Company offers a polyphenol/antioxidant superfruit product called VINIA, which is a red grape powder that supplies the benefits of red wine consumption but without the sugar, calories and alcohol found in wine.
Contact Information
- Headquarters
- 1140 - 625 Howe StreetVANCOUVER, BC, Canada V6C 2T6
- Phone
- 604-622-1186
- Fax
- 604-622-1186
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $149.0M |
|---|---|
Revenue (TTM) | $26.7M |
Shares Outstanding | 17.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.57 |
EPS | $-1.63 |
Book Value | $-1.52 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 5.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
